Archives of Virology

, Volume 47, Issue 2, pp 123–138

An attenuated variant of eastern encephalitis virus: Biological properties and protection induced in mice

  • A. Brown
  • J. E. Officer
Article

Summary

Wild type Eastern equine encephalitis virus (E) was compared with a mutant (Em) derived from it. The latter was tested as an attenuated vaccine in mice. They differed in the following properties: Em formed smaller plaques on chick embryo (CE) cell monolayers and, unlike E, did not plaque on mouse embryo (ME) monolayers. Further, Em had a longer latent period and attained a lower peak titer than E after infection of CE cells, was more sensitive than E to chick interferon, and was less virulent for mice (SC and IP routes) and hamsters (IP route) than E. Both viruses were similar in several other properties tested.

The mutant was found to induce a gradient in the specificity of protection in mice against challenge by selected viruses after a single subcutaneous injection of living virus. The protection was best against autologous (Em) challenge, was next best against challenge by the virulent parent (E) virus, but was not demonstrable against cross challenge by Venezuelan encephalitis (V) virus. Conventional hemagglutination-inhibiting (HI), complement-fixing (CF), and neutralizing (N) antibodies could not be detected in Em-immunized mice even when fresh monkey or guinea pig serum was included in N tests to provide complement and/or accessory factor(s). However, N antibodies were detected in protected mice by an indirect antiglobulin test. Passive protection by serum or ascites fluids (a. f.) was characterized by a lower but otherwise similar protection gradient like that found after active immunization with virus as described above. Interferon was not detected in the a.f. used for passive protection, nor was heterologous interference evident in Em immunized mice challenged 18 days later with vaccinia or vesicular stomatitis virus. Immunized mice that survived autologous (Em) challenge showed broadened protection against a second challenge by parent E virus, and cross protection against V virus. This typical protection was associated with the presence of HI and conventional N antibodies, except for V which showed no detectable neutralizing antibodies by either a standard or antiglobulin technique.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Berge, T. O., I. S. Banks, andW. D. Tigertt: Attenuation of Venezuelan equme encephalomylitis virus byin vitro cultivation in guinea pig heart cells. Amer. J. Hyg.73, 209–218 (1961).Google Scholar
  2. 2.
    Bradish, C. J., K. Allison, andH. B. Maber: Infection, interactions, and expression of virulence by defined strains of Semliki Forest virus. J. gen. Virol.16, 359–372 (1972).Google Scholar
  3. 3.
    Brown, A.: Differences in maximum and minimum plaque-forming temperatures among selected group A arboviruses. Virology21, 362–372 (1963).Google Scholar
  4. 4.
    Brown, A., V. Elsner, E. Zebovitz, andW. P. Allen: Use of an antiglobulin plaque neutralization test among group A arboviruses. Proc. Soc. exp. Biol. (N. Y.)130, 718–722 (1969).Google Scholar
  5. 5.
    Burge, B. W., andE. R. Pfefferkorn: Complementation between temperature-sensitive mutants of Sindbis virus. Virology30, 214–223 (1966).Google Scholar
  6. 6.
    Casals, J.: Relationships among arthropod-borne animal viruses determined by cross challenge tests. Amer. J. trop. Med. Hyg.12, 587–596 (1963).Google Scholar
  7. 7.
    Casals, J., S. M. Buckley, andD. W. Barry: Resistance to arbovirus challenge in mice immediately after vaccination. Appl. Microbiol.25, 755–762 (1973).Google Scholar
  8. 8.
    Cole, F. E., Jr., andR. W. McKinney: Cross protection in hamsters immunized with group A arbovirus vaccines. Infect. and Immun.4, 37–43 (1971).Google Scholar
  9. 9.
    Colon, J. E., J. B. Idoine, O. M. Brand, andR. D. Costlow: Mode of action of an inhibitor from agar on growth and hemagglutination of group A arboviruses. J. Bact.90, 172–179 (1965).Google Scholar
  10. 10.
    Colter, J. S., J. B. Campbell, andL. R. Hatch: The pathogenicity in mice of three variants of Mengo encephalomyelitis virus. J. cell. comp. Physiol.65, 229 to 236 (1965).Google Scholar
  11. 11.
    Griffin, D. E., andR. T. Johnson: Cellular immune response to viral infection:In vitro studies of lymphocytes from mice infected with Sindbis virus. Cellular Immunology9, 426–434 (1973).Google Scholar
  12. 12.
    Grossberg, S.: The interferons and their inducers: Molecular and therapeutic considerations. New Engl. J. Med.287, 79–86 (1972).Google Scholar
  13. 13.
    Hammon, W. M.: In: Diagnostic Procedures for Viral and Rickettsial Infections. Chapter 6: 227–280 (Lennette andSchmidt eds.) American Public Health Assoc., New York (1969).Google Scholar
  14. 14.
    Hammon, W. M., S. Rohitayodhin, andJ. S. Rhim: Studies on Japanese B encephalitis virus vaccines from tissue culture. IV. Preparation and characterization of pool of attenuated OCT-541 line for human vaccine trials. J. Immunol.91, 295–305 (1963).Google Scholar
  15. 15.
    Hearn, H. J., Jr.: Cross-protection between Venezuelan equine encephalomyelitis and Eastern equine encephalomyelitis virus. Proc. Soc. exp. Biol. (N. Y.)107, 607–610 (1961).Google Scholar
  16. 16.
    Hearn, H. J., Jr., A. Brown, andF. M. Hardy: Alteration of virulence of Venezuelan equine encephalomyelitis virus after passage in L cell cultures and in mice. J. infect. Dis.108, 237–242 (1961).Google Scholar
  17. 17.
    Hearn, H. J., Jr., andC. T. Rainey: Cross-protection in animals infected with group A arboviruses. J. Immunol.90, 720–724 (1963).Google Scholar
  18. 18.
    Huang, A. S., andD. Baltimore: Defective viral particles and viral disease processes. Nature (Lond.)226, 325–327 (1970).Google Scholar
  19. 19.
    Jordan, G. W.: Interferon ssnsitivity of Venezuelan equine encephalomyelitis virus. Infect. Immun.7, 911–917 (1973).Google Scholar
  20. 20.
    Maassab, H. F., T. Francis, Jr., F. M. Davenport, A. V. Hennessey, E. Minuse, andG. Anderson: Laboratory and clinical characteristics of attenuated strains of influenza virus. Bull. Wld Hlth Org.41, 589–594 (1969).Google Scholar
  21. 21.
    Mika, L. A., J. E. Officer, andA. Brown: Inactivation of two Arboviruses and their associated infectious nucleic acids. J. infect. Dis.13, 195–203 (1963).Google Scholar
  22. 22.
    Morgan, I. M.: Influence of age on susceptibility and on immune response of mice to Eastern equine encephalomyelitis virus. J. exp. Med.74, 115–132 (1941).Google Scholar
  23. 23.
    Price, W. H., I. S. Thind, W. D. Leary, andA. H. El Dadah: A protective mechanism induced by live group B arboviruses independent of serum neutralizing antibodies or interferon. Amer. J. Epidem.86, 11–27 (1967).Google Scholar
  24. 24.
    Rabinowitz, S. G., andR. A. Proctor:In vitro study of antiviral activity of immune spleen cells in experimental Venezuelan equine encephalomyelitis infection in mice. J. Immunol.112, 1070–1077 (1974).Google Scholar
  25. 25.
    Reed, L. J., andH. Muench: A simple method of estimating fifty percent endpoints. Amer. J. Hyg.27, 493–497 (1938).Google Scholar
  26. 26.
    Schlesinger, R. W.: Interference between animal viruses. In: The Viruses 3, pp. 157–194 (Burnet andStanley, eds.). New York: Academic Press, 1959.Google Scholar
  27. 27.
    Schlesinger, S., M. Schlesinger, andB. W. Burge: Defective virus particles from Sindbis virus. Virology48, 615–617 (1972).Google Scholar
  28. 28.
    Shenk, T. E., andV. Stollar: Defective-interfering particles of Sindbis virus I. Isolation and some chemical and biological properties. Virology53, 162–173 (1973).Google Scholar
  29. 29.
    Theiler, M.: In: Yellow Fever (Strode, G. E., ed.), pp. 39–136. New York: McGraw-Hill, 1951.Google Scholar
  30. 30.
    Thind, I. S., andW. H. Price: Passive transfer of acquired resistance in mice of group B arboviruses by serum protective factor(s) (SPF) independent of serum neutralizing antibody or interferon. Amer. J. Epidem.88, 287 (1968).Google Scholar
  31. 31.
    Thiry, L.: Chemical mutagenesis of Newcastle disease virus. Virology19, 225–236 (1963).Google Scholar
  32. 32.
    Wagner, R. R., A. H. Levy, andT. J. Smith: Techniques for the study of interferons in animal virus-cell systems. In: Methods in Virology. (Maramorosch andKoprowski eds.), IV, 1–52. New York: Academic Press, 1968.Google Scholar
  33. 33.
    Zebovitz, E., andA. Brown: Interference among group A arboviruses. J. Virol.2, 1283–1289 (1968).Google Scholar

Copyright information

© Springer-Verlag 1975

Authors and Affiliations

  • A. Brown
    • 1
    • 2
  • J. E. Officer
    • 1
    • 2
  1. 1.Department of MicrobiologyUniversity of TennesseeKnoxville
  2. 2.Department of PathologyUniversity of Southern CaliforniaLos AngelesUSA

Personalised recommendations